13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 73 holding rows worth $3,372,652,431 by the sum of the rows.
- Accession
- 0001920938-25-000002
- Filer
- CIK 1920938
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 73 entries on the cover page, a total value of $3,862,183,431 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,372,652,431 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The cover page states a total of $3,862,183,431, 15% more than the sum of the rows, $3,372,652,431. This page uses the sum of the rows.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 268,252,000 | $226,002,310 | dollars as filed | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 140,838,000 | $148,147,492 | dollars as filed | principal |
| NOVOCURE LTD | 67011XAB9 | NOTE 11/0 | 140,834,000 | $134,496,470 | dollars as filed | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 901,790 | $123,094,335 | dollars as filed | |
| REPLIGEN CORP | 759916AD1 | NOTE 1.000%12/1 | 112,000,000 | $114,800,000 | dollars as filed | principal |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,913,964 | $114,227,389 | dollars as filed | |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 114,206,000 | $113,206,698 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 116,381,000 | $98,269,207 | dollars as filed | principal |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 2,977,951 | $96,902,526 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 3,283,317 | $94,165,532 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 2,847,931 | $87,004,292 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333XAH1 | NOTE 1.500% 6/1 | 92,740,000 | $85,206,067 | dollars as filed | principal |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 375,179 | $78,228,573 | dollars as filed | |
| DEXCOM INC | 252131AM9 | NOTE 0.375% 5/1 | 82,700,000 | $74,381,594 | dollars as filed | principal |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,540,362 | $69,778,399 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 3,452,447 | $68,289,402 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 2,098,866 | $66,974,814 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 705,391 | $63,605,106 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,332,196 | $62,269,633 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 4,873,853 | $61,751,718 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,578,404 | $60,025,245 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,479,666 | $59,541,760 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 922,100 | $57,492,935 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 58,217,000 | $55,090,747 | dollars as filed | principal |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 293,410 | $54,392,346 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 80,766 | $49,671,090 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 89,754 | $46,692,723 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 53,594,000 | $45,983,652 | dollars as filed | principal |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 8,353,287 | $45,525,414 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 364,900 | $44,368,191 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 183,828 | $43,655,473 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 288,876 | $43,314,067 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 4,105,726 | $43,151,180 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 283,823 | $40,853,483 | dollars as filed | |
| PARAGON 28 INC | 69913P105 | COM | 3,834,809 | $39,613,577 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 75,300 | $39,303,588 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 4,256,490 | $39,074,578 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 309,865 | $35,309,117 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 2,000,659 | $34,851,480 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 200,500 | $31,410,330 | dollars as filed | |
| HARROW INC | 415858109 | COM | 907,039 | $30,431,158 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,894,439 | $29,988,969 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 1,147,676 | $27,096,090 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,206,589 | $26,303,640 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,107,770 | $25,678,109 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,503,965 | $24,913,191 | dollars as filed | |
| GERON CORP | 374163103 | COM | 7,006,315 | $24,802,355 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 5,440,277 | $24,100,427 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 353,200 | $20,704,584 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 353,000 | $19,835,070 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 241,235 | $18,883,876 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 222,424 | $18,207,629 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,477,102 | $17,887,705 | dollars as filed | |
| DEXCOM INC | 252131AK3 | NOTE 0.250%11/1 | 18,500,000 | $17,874,832 | dollars as filed | principal |
| AMPHASTAR PHARMACEUTICALS IN | 03209RAB9 | NOTE 2.000% 3/1 | 17,400,000 | $16,279,440 | dollars as filed | principal |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 681,182 | $16,048,648 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 714,658 | $15,279,388 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,176,173 | $14,325,787 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 615,531 | $14,144,902 | dollars as filed | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 1,600,000 | $13,888,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 802,100 | $11,943,269 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 884,306 | $11,575,566 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,225,448 | $6,825,745 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 1,698,768 | $6,319,417 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,472,806 | $6,182,015 | dollars as filed | |
| CERIBELL INC | 15678C102 | COMMON STOCK | 210,000 | $5,434,800 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 752,541 | $5,109,753 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,440,499 | $3,817,322 | dollars as filed | |
| CUTERA INC | 232109AG3 | NOTE 4.000% 6/0 | 29,000,000 | $2,610,000 | dollars as filed | principal |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 825,732 | $2,336,822 | dollars as filed | |
| CUTERA INC | 232109AD0 | NOTE 2.250% 6/0 | 25,240,000 | $2,271,600 | dollars as filed | principal |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 20,109 | $776,207 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 34,094 | $653,582 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001920938-25-000002 | this filing | 2025-02-14 | acceptance time not in the bulk data set |